|
Dr. Christine V. Sapan, Ph.D. was appointed Executive Vice President, Chief Development Officer of Neurologix in July of 2006. Prior to joining Neurologix, Dr. Sapan was employed for 18 years by Nabi Biopharmaceuticals, a vertically integrated biopharmaceutical company that focuses on serious unmet medical needs including infectious diseases, most recently serving as Vice President, Project Management, from 2001 to 2005. During her tenure with Nabi, Dr. Sapan played a key role in the management of the company�s research programs and the commercial expansion of its therapeutic products. Earlier in her career, Dr. Sapan worked and consulted for a number of technology-based diagnostic companies, including Beckman-Coulter, as a regulatory affairs advisor. Dr. Sapan has a Ph.D in Experimental Pathology and an M.S. in Human Physiology from the University of North Carolina and performed independent research at Duke University as a post-doctoral fellow. | 